Department of Radiation Oncology, Yonsei University College of Medicine
Prof. Kim Jin-sung, (CEO, OncoSoft)
Session Preview ｜#TBD
TBD
Speaker Introduction ｜
Professor, Department of Radiation Oncology, Yonsei University College of Medicine
CEO, Oncosoft Co., Ltd.
1996–2000 B.S., Department of Nuclear and Quantum Engineering, KAIST
2000–2003 M.S., Department of Nuclear and Quantum Engineering, KAIST
2003–2007 Ph.D., Department of Nuclear and Quantum Engineering, KAIST
2007–2009 Proton Therapy Center, National Cancer Center
2009–2016 Proton Therapy Center, Samsung Medical Center
2016– Associate Professor, Department of Radiation Oncology, Yonsei University College of Medicine; Head Professor, Yonsei Heavy Ion Therapy Center
Chung-Ang University Gwangmyeong Hospital
Prof. Cho Jun-hwan
Session Preview ｜#SmartHospital #DigitalTransformation #AX #AI #HealthcareBigData
This session introduces Chung-Ang University Medical Center’s vision and execution strategy for AX—AI-driven digital transformation—across the entire healthcare process, moving beyond the concept of a “smart hospital.”
Centered on real-world use cases, it examines how data and AI can be connected across clinical care, administration, research, and patient experience, and how these connections can be scaled to improve operational efficiency and quality of care.
The session also shares the governance, talent development, and direction for a sustainable smart hospital model needed for medical staff and the organization to transform together.
Speaker Introduction ｜
Professor, Department of Cardiology, Chung-Ang University Gwangmyeong Hospital
Deputy Director, Office of Digital Information Innovation, Chung-Ang University Gwangmyeong Hospital
Deputy Head, Department of Digital Healthcare, Chung-Ang University Medical Center
Specialist in percutaneous coronary intervention (PCI) and cardiac rehabilitation
Research in AI- and wearable device-based diagnosis and monitoring of cardiovascular disease
Leading innovation in clinical care and administration at Chung-Ang University Medical Center through smart hospital initiatives, medical big data, and AI-based digital healthcare
A Clear Roadmap from Reliability to a Governance Framework Ready for Validation and Deployment in Real-World Operating Environments
Omi Korea Solutions Co., Ltd.Do
Thi Thuy Van, CEO
Session Preview ｜#HospitalAX #AIAgent #AIFramework #HospitalReservationSupportSystem #OmiMedial
AI agents are gaining attention as a key technology capable of transforming operational efficiency and patient experience in healthcare services. However, in the medical field, an approach that considers not only technical performance but also safety, reliability, regulation, and real-world operating environments is essential.
This session examines the latest global trends in medical AI agents and the key challenges to consider when applying them to the domestic healthcare market, and shares practical AI adoption strategies for the clinical setting through a healthcare-specialized AI agent framework and a hospital reservation support system built on a rule-based AI agent.
Speaker Introduction ｜
CEO, Omi Korea Solutions LLC
Vice President, OmiGroup
Over 16 years of global business and technology leadership in software development, systems integration (SI), and IT consulting
Extensive experience managing diverse projects and organizations at global companies
Oversees global SI business and AX/DX projects based on AI, Cloud, and Digital Healthcare
Supports corporate AI innovation and digital transformation through a Global SI collaboration model connecting Korea and Vietnam
Molecular You
Dr. Rob Fraser, Ph.D, President, Chief Scientific Officer and Founder
Session Preview ｜#Multi-omics, Scientific Validation Engine, Trial Optimization, Korean partnerships
MY’s systems-based multi-omics platform analyzes proteins and metabolites as interconnected biological systems,
informing care before symptoms appear.
Through Korean partnerships, MY introduces itself as a broad validation engine for pharma, integrative medicine,
and wellness sectors.
Speaker Introduction ｜
President, Chief Scientific Officer and Founder
Rob Fraser was the founding CEO and is the current President and CSO of Molecular You Corporation.
Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry and regulatory compliance, Rob drives the innovation behind Molecular You’s multi-biomarker analytics.
In an Era of Connected Hospitals, Technology & Data.
NuboMed: Empowering Next Generations of Hospitals with Physical AI & Autonomous Decision-Making
Shenzhen NuboMed Medical Technology Co., Ltd.
Zhou Xinghan(JOE), CEO of NuboMed
Session Preview ｜#Next Generations, AI, Autonomous Decision-Making
Against the backdrop of increasingly connected hospitals, this session will share NuboMed’s perspectives on the evolution of healthcare delivery and explore new possibilities for creating smarter, more adaptive, and future-ready healthcare environments.
Speaker Introduction ｜
CEO of NuboMed
Zhou Xinghan holds a B.S. in Electrical Engineering from UC Irvine and built his career at global tech companies including Cisco, Telematics, and Advantech.
In 2012, driven by his expertise in digital healthcare, he founded Shenzhen NuboMed Medical Technology and was named a Shenzhen “Peacock Plan” Talent.
Under his leadership as CEO, NuboMed has evolved from developing mobile nursing terminals into a full-scale provider of smart ward construction, closed-loop medication management, and AI-driven IoT smart hospital solutions.
Kim & Chang
Kim Do-yeop, Attorney
Session Preview ｜#Medical AI #Medical Data
This lecture provides a comprehensive review of the key personal data protection issues arising in the development and use of AI with healthcare data, along with corresponding response strategies. The discussion focuses on the legal grounds for processing personal data, the pseudonymization procedures and practical considerations for AI training purposes, and the required measures for the overseas transfer of healthcare data. It also introduces the Personal Information Protection Commission’s one-stop innovation support service and the pre-clearance opinion system (비조치의견서), and presents practical application approaches in the healthcare AI field based on real-world cases. Through this, the session seeks to explore a direction in which the safe use of healthcare data and AI innovation can be harmonized.
Speaker Introduction ｜
Speaker Introduction
Attorney Kim Do-yeop is an IT and telecommunications specialist attorney at Kim & Chang, handling personal data, data governance, and AI regulation matters. He has advised hospitals and other medical institutions on the use of healthcare data, pseudonymization, building data governance for medical AI services, and overseas data transfers. He currently serves as Advisory Attorney and Pseudonymized Information Expert for the Personal Information Protection Commission, and as an Adjunct Professor at Korea University’s Graduate School of Information Security. He also holds certifications as an ISMS-P Certification Auditor and a Personal Information Impact Assessment (PIA) Professional.
